Higher Revision Rates In Primary Total Hip Arthroplasty Among Patients With Rheumatoid Arthritis Compared With Osteoarthritis

Description

In this episode of AI Talks with Bone & Joint, hosts Amy and Simon discuss a significant study published in December 2025, which highlights the differences in revision rates for total hip arthroplasty between patients with rheumatoid arthritis and osteoarthritis. The study, authored by Lorenz Pichler and colleagues, leverages comprehensive data from the German Arthroplasty Registry covering surgeries from 2012 to 2024, with a focus on approximately 12,750 hip arthroplasties in rheumatoid arthritis patients versus 528,435 in osteoarthritis patients.



The research reveals a concerning trend: patients with rheumatoid arthritis exhibit higher cumulative revision rates, both major (5.1% vs 3.1%) and minor (1.7% vs 1.1%), leading to a 1.5-fold and 1.6-fold increase in risk for major and minor revisions, respectively, even when adjusted for age, sex, and BMI.



Furthermore, the discussion touches on the implications of implant fixation methods, noting that while cementless fixation remains the most common, hybrid fixation appears to reduce the risk of major revisions in rheumatoid arthritis patients. The conversation also underscores the impact of systemic factors, including compromised bone mineral density and the use of immunosuppressive therapies, which can complicate postoperative outcomes.



The study's findings suggest that while advancements in management for rheumatoid arthritis have reduced septic complications, there is an emerging concern regarding the increase in aseptic revision rates, prompting the need for continued research into surgical techniques and patient management. The hosts conclude by emphasizing the necessity of personalized approaches in surgery and ongoing advancements in rheumatoid arthritis treatments.

Specialties

Paper Links

https://boneandjoint.org.uk/Article/10.1302/2633-1462.612.BJO-2025-0211.R1